Book Appointment Now
Whistleblower Protection Policy
Effective date: 01/04/2026
At SIDAPHARM P.C., we are committed to protecting individuals who report in good faith concerns related to bribery, corruption, misconduct, ethical violations, violations of company policies, or suspected non-compliance with legal or regulatory requirements, in accordance with ISO 37001:2025 requirements and applicable whistleblower protection legislation.
The company encourages employees, suppliers, contractors, business partners, and other stakeholders to report unethical, illegal, or suspicious activities without fear of retaliation.
Reports may be submitted confidentially or anonymously through designated reporting channels.
Reporting Channels
Concerns may be reported through any of the following channels:
• Whistleblowing Officer.
• Directly to the Anti-Bribery Function / QA Manager.
• General Manager.
• Official company email or written communication.
All reports shall be documented, assessed promptly, and investigated impartially.
Rights of the Whistleblower
Whistleblower acting in good faith have the right:
• To report concerns without fear of harassment, dismissal, reprisal, or discrimination.
• To remain anonymous where legally permissible.
• To have their identity protected confidentially.
• To be informed of the outcome of the investigation where possible.
• To access internal or external protection mechanisms where applicable.
Protection Against Retaliation
Retaliation against whistleblowers is strictly prohibited.
Retaliation includes but is not limited to:
• Dismissal, demotion, suspension, or disciplinary action.
• Harassment, intimidation, or discrimination.
• Unjustified changes in duties, work location, salary, or working conditions.
• Threats, coercion, or verbal abuse.
• Social exclusion or professional disadvantage.
Any employee found to have engaged in retaliation shall be subject to disciplinary action up to and including termination of employment.
Confidentiality
All reports, supporting information, and identities of whistleblowers shall be treated as strictly confidential and disclosed only to persons directly involved in investigation or where required by law.
Confidentiality shall be maintained to the maximum extent possible while ensuring effective investigation and legal compliance.
False Reporting
Reports made in good faith are protected, even if allegations are not confirmed.
Deliberate false, malicious, or misleading reports may result in disciplinary action.
Review
This policy shall be reviewed annually or whenever significant legal, organizational, or operational changes occur.
The Whistleblower Protection Policy is communicated within the organization and made available to relevant interested parties.
By adhering to this policy, SIDAPHARM P.C. maintains ethical business conduct, anti-bribery commitment, and compliance with applicable regulatory and management system requirements.
Approved by,
Diana Mochintra
General Manager
At SIDAPHARM P.C., we are committed to protecting individuals who report in good faith concerns related to bribery, corruption, misconduct, ethical violations, violations of company policies, or suspected non-compliance with legal or regulatory requirements, in accordance with ISO 37001:2025 requirements and applicable whistleblower protection legislation.
The company encourages employees, suppliers, contractors, business partners, and other stakeholders to report unethical, illegal, or suspicious activities without fear of retaliation.
Reports may be submitted confidentially or anonymously through designated reporting channels.
Reporting Channels
Concerns may be reported through any of the following channels:
• Whistleblowing Officer.
• Directly to the Anti-Bribery Function / QA Manager.
• General Manager.
• Official company email or written communication.
All reports shall be documented, assessed promptly, and investigated impartially.
Rights of the Whistleblower
Whistleblower acting in good faith have the right:
• To report concerns without fear of harassment, dismissal, reprisal, or discrimination.
• To remain anonymous where legally permissible.
• To have their identity protected confidentially.
• To be informed of the outcome of the investigation where possible.
• To access internal or external protection mechanisms where applicable.
Protection Against Retaliation
Retaliation against whistleblowers is strictly prohibited.
Retaliation includes but is not limited to:
• Dismissal, demotion, suspension, or disciplinary action.
• Harassment, intimidation, or discrimination.
• Unjustified changes in duties, work location, salary, or working conditions.
• Threats, coercion, or verbal abuse.
• Social exclusion or professional disadvantage.
Any employee found to have engaged in retaliation shall be subject to disciplinary action up to and including termination of employment.
Confidentiality
All reports, supporting information, and identities of whistleblowers shall be treated as strictly confidential and disclosed only to persons directly involved in investigation or where required by law.
Confidentiality shall be maintained to the maximum extent possible while ensuring effective investigation and legal compliance.
False Reporting
Reports made in good faith are protected, even if allegations are not confirmed.
Deliberate false, malicious, or misleading reports may result in disciplinary action.
Review
This policy shall be reviewed annually or whenever significant legal, organizational, or operational changes occur.
The Whistleblower Protection Policy is communicated within the organization and made available to relevant interested parties.
By adhering to this policy, SIDAPHARM P.C. maintains ethical business conduct, anti-bribery commitment, and compliance with applicable regulatory and management system requirements.
Approved by,
Diana Mochintra
General Manager
